Top

Reactions Weekly

Published in:

01-09-2021 | Cystitis | Case report

Cyclophosphamide/fludarabine

Various toxicities: 5 case reports

Published in: Reactions Weekly | Issue 1/2021

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

George B, et al. An Antithymocyte Globulin-Free Conditioning Regimen Using Fludarabine and Cyclophosphamide Is Associated with Good Outcomes in Patients Undergoing Matched Related Family Donor Transplantation for Aplastic Anemia. Transplantation and Cellular Therapy 27: 409e1-409e6, No. 5, May 2021. Available from: URL: http://doi.org/10.1016/j.jtct.2021.01.029

Title: Cyclophosphamide/fludarabine
Various toxicities: 5 case reports
Publication date: 01-09-2021
Publisher: Springer International Publishing
Keywords: Cystitis
Idiopathic Intracranial Hypertension
Aciclovir
Myocardial Infarction
Cystitis
Hypertension
Hypertension
Published in: Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-02082-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cyclophosphamide/fludarabine

Various toxicities: 5 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Antiplatelet drugs/heparin/ondansetron

Acenocoumarol/amoxicillin/clavulanic-acid

Multiple drugs overdose/interaction

Bortezomib/dexamethasone/oxytetracycline

Multiple drugs

Somatropin